SUBJECT INDEX 



889 



Enteritis, regional, utilization of vitamin A 



in aqueous solution, 318, 319 

 Enterogastrone, 179 

 Enterokinase, 123 



Environmental temperature, effect on ani- 

 mal fats, 586-588 



effect on fat utilization, 240 



effect on vegetable fats, 588-591 



fatty acids and, 689 

 Enzymes, acetylesterase, 59 



chlorophyllase, 65-67 



cholesterol esterase, 20-23 



choline acetylase, 61-65 



choline oxidase, 652, 657 



cholinesterases, 26-61 



esterases, 14-19 



factors concerned with activity, 5 



lecithinases, 23-26, 248 



lipases, 5-14 



metabolic classification, 4 



phosphatase, 150, 248 



phytase, 67-69 

 Epicoprostanol, 272, 273 

 Epilepsy, blood lipids in, 482 

 Epimerization of bile acids, 91 

 Epinephrine, effect on fat mobilization, 

 615 



effect on serum lipids, 443, 444 



fat absorption and, 190 

 Erepsin, 123 



Ergobasine, as cholinesterase inhibitor, 35 

 Ergosterol, 269, 270 



effect on cholesterol absorption, 271 



in liver, 713 

 Ergosterol, irradiated, absorption of, 324 

 Ergotamine, cholinesterase inhibitor, 35 

 Erucic acid, absorption of, 224, 225 



effect on adrenal cholesterol, 766 



in milk fat, 525 

 Erythroblastic anemia, blood lipids in, 458 

 Erythrocytes, absence of neutral fat in, 

 358, 381 



cephalin in, 384 



cerebrosides in, 361, 381 



cholesterol in, 363, 381, 384, 461 



choline acetylase in, 64 



cholinesterase in, 52, 53 



elinin in, 374 



Erythrocytes (continued): 



globoside in stroma of, 385 



lecithin in, 384, 414 



lipids in various species, 381, 383-386 



permeability, 44-46 



phospholipid transport and, 353 



phospholipids in, 358-360, 363, 384 



phytase in, 69 



sphingomyelin in, 384 

 Eserine, cell permeability and, 44-46 



cholinesterase inhibition, 30, 34, 39, 41, 

 44,46 



formula, 34 

 Eserine methyliodide, as cholinesterase 



inhibitor, 35 

 Eseroline, as cholinesterase inhibitor, 35 

 Eskimos, blood lipids in, 401 

 Esmodil, as cholinesterase inhibitor, 35 

 Essential cholesterolemia (see Xanthoma- 

 tosis, essential) 

 Essential fatty acids (also see Unsaturated 

 fatty adds) 



deficiency, cerumen production in, 786 

 effect on cholesterol level, 435, 436 

 fatty livers resulting from, 678, 679, 

 688 



fasting effect on tissue, 595 

 Esterase I, 9, 15 

 Esterase II, 9, 15 

 Esterases, 4, 14-19 



constants, 17 



distribution, 14 



factors affecting action, 17, 18 



in cervical lymph, 16 



in serum, 10, 15, 16 



in thoracic and mesenteric lymph, 16 



inhibitors, 17 



origin, 14 



preparation, 18, 19 



properties, 16 



separation from ricinus lipase, 11 



vs. lipase, 19 

 Esters of fatty acids, absorption of, 143 

 Estradiol, effect on fatty livers, 686 



on serum lipids, 454 

 Estradiol benzoate 



effect on blood carotene and vitamin A. 

 494 



